Development Committee. As soon as practicable, the Parties will establish a joint development committee, comprised of at least one (1) and up to two (2) representatives of Omega and at least one (1) and up to two (2) representatives of Acuitas (the “JDC”). One such representative from each Party will be such Party’s Workplan Leader. Each Party may replace its Workplan Leader and other JDC representatives at any time upon written notice to the other Party, provided, however, that each Party shall use reasonable efforts to ensure continuity on the JDC. With the consent of the other Party (which will not be unreasonably withheld, conditioned or delayed), each Party may invite non-voting employees and consultants to attend JDC meetings as necessary, subject to consultant’s agreement to be bound to the same extent as a permitted subcontractor under Section 3.1(i).
Development Committee. The Development Committee shall be responsible for the preparation and execution of fundraising and communication plans to raise the financial resources needed to support the Foundation’s purposes and objectives. The Committee shall consist of three or more members appointed annually by the Foundation Board. The Vice President – Development shall chair the Committee and shall report regularly to the Foundation Board on Committee activities.
Development Committee. The Joint Management Committee will establish a development and commercialization committee (the "Development Committee") to oversee the pre-clinical and clinical Development and Commercialization of Products in the Field, and, if XOMA elects to Co-Promote such Product as provided in Section 4.1 below, Co-Promotion of Products in the Field. Decisions of the Development Committee will be by unanimous agreement; provided, however, that subject to the terms of this Agreement it is agreed that (x) Alexion shall have primary responsibility for clinical development; (y) XOMA shall have primary responsibility for the development of clinical and commercial-scale manufacturing processes and shall have primary responsibility for and control the preparation of chemistry and manufacturing controls documentation and/or submission of any drug master file relating to a Product manufactured by XOMA; and (z) Alexion shall have primary responsibility for pre-launch and other Commercialization activities. Should the members of the Development Committee fail to agree on any matter for which unanimous agreement has been sought and Alexion or XOMA requests a resolution, the matter shall be referred to the JMC for resolution in accordance with Article 12.
Development Committee. 8 3.2 Membership........................................................................................8 3.3
Development Committee. RPRP and Introgen will establish a Development Committee to oversee, review and coordinate the development of Collaboration Products worldwide, including the conduct of the Early Stage Development Program and Later Stage Clinical Development in North America.
Development Committee. The PARTIES agree to work together in good faith in the collaboration under this Agreement and to keep each other reasonably informed of its activities hereunder. Additionally, and in support of the foregoing, promptly after the Effective Date, the PARTIES will form a four-member committee (the “Development Committee”), equally represented by EAGLE and SCIDOSE, for the management of the development of the PRODUCTS, which will consist of the Chief Executive Officer and Chief Scientific Officer of each of EAGLE and SCIDOSE. Each Party shall have the right, from time to time, to substitute new members, on a permanent or temporary basis, for any of its previously designated members of the Development Committee. Each Party shall bear its own costs associated with participation in the Development Committee.
Development Committee. This Oversight Committee shall act as the body to which a teacher or administrator may appeal the LPDC’s decisions regarding the teacher’s/administrator’s IPDP based upon the rules established by the LPDC. In cooperation with Huron county ESC staff, the Oversight Committee shall process all necessary paperwork to the Ohio Department of Education as required for renewal of certificates/licenses.
Development Committee. A. The Association will appoint an Instructional & Professional Development Committee which will consider the future development of curriculum, teaching methods, aids, teaching materials, and educational facilities intended to encourage improvement of the educational program in the Framingham Public Schools. This committee will cooperate with the administrators in the implementation of the educational revisions and shall make recommendations to the Committee at reasonable times by mutual agreement. This committee will be consulted prior to any major change in the area described above.
Development Committee. 17 6.2.1. General............................................ 17 6.2.2. Minutes............................................ 17 (ii) 4 6.3. General Disagreements........................................ 17 6.4. Visit of Facilities.......................................... 18 6.5. Annual Review and Planning Meeting........................... 18
Development Committee. 7 3.1 Members......................................................................7 3.2 Responsibilities.............................................................7 3.3 Meetings.....................................................................7 3.4 Decisions....................................................................8 3.5 Term.........................................................................8 3.6 Expenses.....................................................................8
